marketcaparena
Search

    COR

    Cencora, Inc.

    Company overview

    Market capitalization
    $57.98B
    Employees
    47,000
    Latest publication
    2026-09-29
    About Cencora, Inc.

    Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ3 20262026-06-30 · USDQ2 20262026-03-31 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ3 20242024-06-30 · USDQ2 20242024-03-31 · USDQ1 20242023-12-31 · USDQ4 20232023-09-30 · USD
    Total Revenue84,754,837,000USD78,355,916,000USD80,663,532,000USD75,453,673,000USD74,241,353,000USD68,414,307,000USD72,252,833,000USD68,922,331,000USD
    Cost Of Revenue81,147,602,000USD75,033,407,000USD78,005,131,000USD72,837,849,000USD72,154,776,000USD66,156,729,999USD70,102,872,000USD67,015,687,000USD
    Gross Profit3,607,235,000USD3,322,509,000USD2,658,401,000USD2,615,824,000USD2,086,577,000USD2,257,577,000USD2,149,961,000USD1,906,644,000USD
    Selling General Administrative2,132,465,000USD1,977,559,000USD1,672,881,000USD1,600,040,000USD1,383,206,000USD1,388,810,000USD1,398,747,000USD1,393,828,000USD
    Other Operating Expenses118,539,000USD———————
    Total Operating Expenses2,487,018,000USD1,977,559,000USD1,672,881,000USD1,600,040,000USD1,383,206,000USD1,388,810,000USD1,398,747,000USD1,393,828,000USD
    Operating Income1,120,217,000USD1,344,950,000USD985,520,000USD1,015,784,000USD703,371,000USD868,767,000USD751,214,000USD512,816,000USD
    Total Other Income Expense Net-123,823,000USD743,622,000USD-89,243,000USD-87,128,000USD-75,037,000USD-401,701,000USD32,184,000USD-66,393,000USD
    Litigation Settlement Expense-88,643,000USD———————
    Income Before Tax996,394,000USD2,088,572,000USD896,277,000USD928,656,000USD628,334,000USD467,066,000USD783,398,000USD446,423,000USD
    Income Tax Expense219,727,000USD459,044,000USD206,528,000USD211,239,000USD140,740,000USD45,861,000USD180,390,000USD97,443,000USD
    Net Income776,667,000USD1,641,332,000USD687,402,000USD717,871,000USD483,463,000USD420,775,000USD601,500,000USD350,565,000USD
    Minority Interest13,149,000USD11,804,000USD-2,347,000USD454,000USD-4,131,000USD-430,000USD-1,508,000USD1,585,000USD
    Interest Income—13,881,000USD35,102,000USD28,330,000USD27,608,000USD12,680,000USD18,052,000USD60,942,000USD
    Interest Expense—154,341,000USD116,896,000USD132,318,000USD58,936,000USD76,810,000USD58,616,000USD74,106,000USD
    Net Interest Income—-140,460,000USD-81,794,000USD-103,988,000USD-31,328,000USD-64,130,000USD-40,564,000USD-60,942,000USD
    Tax Provision—459,044,000USD206,528,000USD211,239,000USD140,740,000USD45,861,000USD180,390,000USD97,443,000USD
    Net Income From Continuing Ops—1,629,528,000USD689,749,000USD717,417,000USD487,594,000USD421,205,000USD603,008,000USD348,980,000USD
    Ebit—2,242,913,000USD1,013,173,000USD1,060,974,000USD687,270,000USD543,876,000USD842,014,000USD520,529,000USD
    Ebitda—2,502,371,000USD1,269,396,000USD1,322,574,000USD966,202,000USD821,947,000USD1,118,548,000USD796,755,000USD
    Depreciation And Amortization—259,458,000USD256,223,000USD261,600,000USD278,932,000USD278,071,000USD276,534,000USD276,226,000USD
    Reconciled Depreciation—262,977,000USD258,973,000USD263,973,000USD280,890,000USD279,756,000USD278,445,000USD276,226,000USD
    Net Income Applicable To Common Shares——687,402,000USD717,871,000USD———350,565,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20212021-09-30 · USDFY 20202020-09-30 · USDFY 20192019-09-30 · USDFY 20162016-09-30 · USDFY 20112011-09-30 · USD
    Total Revenue321,332,819,000USD293,958,599,000USD262,173,411,000USD213,988,843,000USD189,893,926,000USD179,589,121,000USD146,849,686,000USD80,217,558,000USD
    Cost Of Revenue311,191,298,000USD285,257,361,000USD254,416,914,000USD207,719,581,000USD185,102,180,000USD175,059,088,000USD143,075,573,000USD77,788,871,000USD
    Gross Profit10,141,521,000USD8,701,238,000USD7,756,497,000USD6,269,261,999USD4,791,746,000USD4,530,033,000USD3,774,113,000USD2,428,687,000USD
    Selling General Administrative6,493,842,000USD5,661,106,000USD5,309,984,000USD3,594,251,000USD80,573,000USD76,388,000USD58,000,000USD41,057,000USD
    Total Operating Expenses6,493,842,000USD5,661,106,000USD5,309,984,000USD3,594,251,000USD2,767,217,000USD2,663,508,000USD2,091,237,000USD1,197,969,000USD
    Operating Income3,647,679,000USD3,040,132,000USD2,446,513,000USD2,675,011,000USD2,024,529,000USD1,866,525,000USD1,682,876,000USD1,230,718,000USD
    Interest Income128,205,000USD91,691,000USD228,931,000USD8,470,000USD20,639,000USD37,705,000USD——
    Interest Expense419,753,000USD248,682,000USD275,650,000USD182,544,000USD158,522,000USD195,474,000USD144,349,000USD78,902,000USD
    Net Interest Income-291,548,000USD-156,991,000USD-228,931,000USD-174,074,000USD-137,883,000USD-157,769,000USD——
    Income Before Tax2,258,336,000USD2,003,975,000USD2,160,836,000USD2,221,859,000USD-5,293,831,000USD967,106,000USD1,390,910,000USD1,130,641,000USD
    Income Tax Expense690,522,000USD484,702,000USD428,260,000USD677,251,000USD-1,894,273,000USD112,971,000USD-37,019,000USD424,017,000USD
    Tax Provision690,522,000USD484,702,000USD428,260,000USD677,251,000USD-1,894,273,000USD112,971,000USD——
    Net Income1,554,169,000USD1,509,120,000USD1,745,293,000USD1,539,932,000USD-3,399,558,000USD855,365,000USD1,427,929,000USD706,624,000USD
    Net Income From Continuing Ops1,567,814,000USD1,519,273,000USD1,732,576,000USD1,544,608,000USD-3,399,558,000USD854,135,000USD——
    Ebit2,678,089,001USD2,252,657,000USD2,436,486,000USD2,404,403,000USD-5,135,309,000USD1,162,580,000USD1,535,259,000USD1,209,543,000USD
    Ebitda3,736,333,000USD3,364,331,000USD3,408,879,000USD2,909,575,000USD-4,733,690,000USD1,651,124,000USD1,920,290,000USD1,330,776,000USD
    Depreciation And Amortization1,058,243,999USD1,111,674,000USD972,393,000USD505,172,000USD401,619,000USD488,544,000USD385,031,000USD121,233,000USD
    Reconciled Depreciation1,068,416,000USD1,118,842,000USD963,904,000USD514,786,000USD391,062,000USD462,407,000USD——
    Total Other Income Expense Net-1,389,343,000USD-1,036,157,000USD-285,677,000USD-453,152,000USD-7,318,360,000USD-899,419,000USD-291,966,000USD-100,077,000USD
    Minority Interest-13,645,000USD-10,153,000USD12,717,000USD-4,676,000USD-9,158,000USD1,230,000USD——
    Net Income Applicable To Common Shares1,554,169,000USD1,509,120,000USD1,745,293,000USD1,539,932,000USD-3,408,716,000USD855,365,000USD——
    Selling And Marketing Expenses————23,726,000USD——5,744,000USD
    Unclassified Operating Expenses————2,662,918,000USD2,587,120,000USD2,033,237,000USD1,151,168,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ3 20262026-06-30 · USDQ2 20262026-03-31 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USD
    Total Assets83,805,553,000USD81,652,100,000USD78,361,214,000USD76,590,112,000USD73,956,905,000USD71,193,874,000USD69,054,314,000USD67,101,667,000USD
    Cash And Equivalents2,815,291,000USD—1,753,122,000USD4,356,138,000USD2,231,852,000USD1,978,061,000USD3,224,260,000USD3,132,648,000USD
    Total Current Assets55,335,137,000USD53,140,911,000USD54,151,576,000USD52,239,073,000USD48,814,161,000USD46,534,973,000USD49,986,634,000USD47,717,813,000USD
    Other Current Assets636,051,000USD6,001,423,000USD2,284,469,000USD2,165,156,000USD1,882,727,000USD1,876,402,000USD1,708,630,000USD1,714,517,000USD
    Other Non Current Assets3,006,600,000USD———————
    Total Liabilities80,566,462,000USD———————
    Total Current Liabilities59,197,103,000USD56,132,286,000USD59,132,139,000USD57,820,539,000USD53,958,034,000USD53,328,382,000USD54,509,105,000USD54,277,053,000USD
    Other Current Liabilities3,348,462,000USD———————
    Other Non Current Liabilities3,969,412,000USD———————
    Total Stockholder Equity3,050,958,000USD3,397,590,000USD1,908,328,000USD1,508,019,000USD1,980,193,000USD1,012,837,000USD226,580,000USD645,938,000USD
    Total Equity Including Noncontrolling Interest3,239,091,000USD———————
    Long Term Debt11,444,086,000USD12,259,105,000USD7,579,459,000USD7,542,988,000USD8,043,699,000USD7,085,886,000USD5,935,321,000USD3,811,745,000USD
    Net Receivables25,448,105,000USD24,893,220,000USD25,979,920,000USD25,225,299,000USD24,561,733,000USD23,715,008,000USD24,545,724,000USD23,871,815,000USD
    Inventory21,030,344,000USD20,010,006,000USD24,078,494,000USD20,492,480,000USD20,137,849,000USD18,965,502,000USD20,508,020,000USD18,998,833,000USD
    Property Plant Equipment Net2,838,218,000USD2,805,419,000USD2,450,799,000USD4,087,554,000USD2,431,376,000USD2,302,809,000USD2,099,787,000USD3,323,032,000USD
    Goodwill16,515,457,000USD———————
    Intangible Assets5,930,723,000USD6,054,716,000USD3,678,727,000USD3,774,181,000USD3,929,054,000USD3,862,835,000USD3,682,211,000USD4,001,046,000USD
    Accounts Payable54,699,786,000USD51,881,816,000USD56,063,820,000USD54,719,761,000USD51,043,874,000USD50,110,563,000USD49,910,853,000USD50,942,162,000USD
    Short Term Debt279,155,000USD202,660,000USD342,276,000USD371,555,000USD196,787,000USD770,321,000USD2,213,226,000USD781,098,000USD
    Common Stock2,983,000USD2,983,000USD2,983,000USD2,974,000USD2,973,000USD2,972,000USD2,971,000USD2,962,000USD
    Retained Earnings9,138,163,000USD8,491,234,000USD6,967,358,000USD6,534,227,000USD6,981,443,000USD6,401,534,000USD5,794,851,000USD5,417,139,000USD
    Accumulated Other Comprehensive Income-979,744,000USD-961,308,000USD-905,078,000USD-901,378,000USD-844,238,000USD-1,201,838,000USD-1,399,624,000USD-989,118,000USD
    Total Liab—78,067,150,000USD76,265,246,000USD74,843,027,000USD71,747,014,000USD70,014,075,000USD68,692,412,000USD66,314,925,000USD
    Other Current Liab—3,695,042,000USD2,374,553,000USD2,391,592,000USD2,411,076,000USD2,169,760,000USD2,081,593,000USD2,261,997,000USD
    Capital Stock—2,983,000USD2,983,000USD2,974,000USD2,973,000USD2,972,000USD2,971,000USD2,962,000USD
    Good Will—16,452,669,000USD13,730,761,000USD13,676,520,000USD14,326,057,000USD14,091,412,000USD9,177,245,000USD9,318,027,000USD
    Cash—2,236,262,000USD1,808,693,000USD4,394,549,000USD2,275,326,000USD2,110,359,000USD3,327,512,000USD3,231,244,000USD
    Cash And Short Term Investments—2,236,262,000USD1,808,693,000USD4,394,549,000USD2,275,326,000USD2,110,359,000USD3,327,512,000USD3,231,244,000USD
    Net Debt—10,149,258,000USD6,113,042,000USD6,353,260,000USD5,965,160,000USD5,745,848,000USD4,821,035,000USD3,421,555,000USD
    Short Long Term Debt—126,415,000USD342,276,000USD117,785,000USD196,787,000USD770,321,000USD2,213,226,000USD576,331,000USD
    Short Long Term Debt Total—12,385,520,000USD7,921,735,000USD10,747,809,000USD8,240,486,000USD7,856,207,000USD8,148,547,000USD6,652,799,000USD
    Common Stock Shares Outstanding—195,383,000shares195,319,000shares193,899,000shares195,230,000shares195,094,000shares195,188,000shares200,284,000shares
    Non Current Assets Total—28,511,189,000USD24,209,638,000USD24,351,039,000USD25,142,744,000USD24,658,901,000USD19,067,680,000USD19,383,854,000USD
    Non Current Liabilities Total—21,934,864,000USD17,133,107,000USD17,022,488,000USD17,788,980,000USD16,685,693,000USD14,183,307,000USD12,037,872,000USD
    Non Current Liabilities Other—3,718,330,000USD3,697,605,000USD3,639,862,000USD3,539,659,000USD3,421,715,000USD2,061,715,000USD1,993,683,000USD
    Non Currrent Assets Other—3,005,560,000USD4,142,530,000USD2,603,974,000USD4,227,970,000USD4,099,938,000USD3,821,558,000USD2,428,765,000USD
    Net Working Capital—-2,991,375,000USD-4,980,563,000USD-5,581,466,000USD-5,143,873,000USD-6,793,409,000USD-4,522,471,000USD-6,559,240,000USD
    Unclassified Non Current Liabilities—5,957,429,000USD5,856,043,000USD5,839,638,000USD6,205,622,000USD6,178,092,000USD6,186,271,000USD6,232,444,000USD
    Unclassified Equity—-4,138,302,000USD-4,159,918,000USD-4,130,778,000USD-4,162,958,000USD-4,192,803,000USD-4,174,589,000USD-3,788,007,000USD
    Other Assets——4,349,351,000USD4,361,262,000USD4,456,257,000USD4,401,845,000USD4,108,437,000USD3,883,371,000USD
    Unclassified Non Current Assets——-4,142,530,000USD-4,152,452,000USD-4,227,970,000USD-4,099,938,000USD-3,821,558,000USD-3,570,387,000USD
    Property Plant Equipment Gross———5,733,318,000USD———5,215,090,000USD
    Unclassified Current Liabilities——————-1,909,793,000USD-576,331,000USD
    Current Deferred Revenue———————291,796,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USDFY 20202020-09-30 · USDFY 20192019-09-30 · USDFY 20182018-09-30 · USD
    Total Assets76,590,112,000USD67,101,667,000USD62,558,746,000USD56,560,616,000USD57,337,805,000USD44,274,830,000USD39,171,980,000USD37,669,838,000USD
    Intangible Assets3,774,181,000USD4,001,046,000USD4,431,783,000USD4,332,737,000USD5,256,927,000USD1,886,107,000USD2,294,836,000USD2,947,828,000USD
    Other Current Assets2,126,745,000USD1,714,517,000USD1,840,926,000USD342,891,000USD2,498,065,000USD1,533,949,000USD1,310,727,000USD169,122,000USD
    Total Liab74,843,027,000USD66,314,925,000USD61,892,459,000USD56,489,343,000USD56,753,394,000USD45,114,466,000USD36,466,412,000USD34,968,179,000USD
    Total Stockholder Equity1,508,019,000USD645,938,000USD522,003,000USD-211,559,000USD223,354,000USD-1,018,924,000USD2,878,917,000USD2,932,824,000USD
    Other Current Liab2,391,592,000USD2,261,997,000USD1,860,679,000USD1,775,338,000USD2,592,052,000USD1,269,330,999USD773,133,000USD581,557,000USD
    Common Stock2,974,000USD2,962,000USD2,948,000USD2,927,000USD2,907,000USD2,878,000USD2,853,000USD2,836,000USD
    Capital Stock2,974,000USD2,962,000USD2,948,000USD2,927,000USD2,907,000USD2,878,000USD2,853,000USD—
    Retained Earnings6,534,227,000USD5,417,139,000USD4,324,187,000USD2,977,646,000USD1,670,513,000USD518,335,000USD4,235,491,000USD3,720,582,000USD
    Good Will13,676,520,000USD9,318,027,000USD9,574,117,000USD8,503,886,000USD9,030,531,000USD6,706,719,000USD6,705,507,000USD6,664,272,000USD
    Other Assets2,812,784,000USD2,741,749,000USD3,618,849,000USD1,054,258,000USD1,017,602,000USD697,972,000USD269,067,000USD—
    Cash4,394,549,000USD3,231,244,000USD2,689,773,000USD3,533,169,000USD2,547,142,000USD4,597,746,000USD3,374,194,000USD2,492,516,000USD
    Cash And Equivalents4,356,138,000USD3,132,648,000USD2,592,051,000USD3,388,189,000USD2,547,142,000USD4,597,746,000USD——
    Cash And Short Term Investments4,394,549,000USD3,231,244,000USD2,689,773,000USD3,533,169,000USD2,547,142,000USD4,597,746,000USD3,374,194,000USD2,492,516,000USD
    Total Current Assets52,239,073,000USD47,717,813,000USD42,798,826,000USD39,589,758,000USD38,802,609,000USD33,019,853,000USD28,132,054,000USD25,894,372,000USD
    Total Current Liabilities57,820,539,000USD54,277,053,000USD48,831,198,000USD43,477,955,000USD41,358,641,000USD33,853,077,000USD29,581,294,000USD27,869,687,000USD
    Net Debt6,353,260,000USD3,421,555,000USD4,128,640,000USD4,056,424,000USD6,204,444,000USD385,375,000USD1,119,216,000USD2,169,969,000USD
    Short Term Debt371,555,000USD781,098,000USD823,806,000USD1,228,657,000USD475,565,000USD593,846,000USD139,012,000USD151,657,000USD
    Short Long Term Debt117,785,000USD576,331,000USD641,344,000USD1,070,473,000USD300,213,000USD501,259,000USD139,012,000USD—
    Short Long Term Debt Total10,747,809,000USD6,652,799,000USD6,818,413,000USD7,589,593,000USD8,751,586,000USD4,983,121,000USD4,493,410,000USD4,662,485,000USD
    Long Term Debt7,542,988,000USD3,811,745,000USD4,146,113,000USD4,632,360,000USD6,383,711,000USD3,618,261,000USD4,033,880,000USD—
    Net Receivables25,225,299,000USD23,871,815,000USD20,911,081,000USD18,625,243,000USD18,389,050,000USD14,298,880,000USD12,386,879,000USD11,314,226,000USD
    Inventory20,492,480,000USD18,998,833,000USD17,454,768,000USD17,088,455,000USD15,368,352,000USD12,589,278,000USD11,060,254,000USD11,918,508,000USD
    Accounts Payable54,719,761,000USD50,942,162,000USD45,836,037,000USD40,192,890,000USD38,009,954,000USD31,705,055,000USD28,385,074,000USD26,836,873,000USD
    Property Plant Equipment Net4,087,554,000USD3,323,032,000USD3,154,539,000USD3,079,977,000USD3,230,136,000USD1,928,330,000USD1,770,516,000USD1,892,424,000USD
    Property Plant Equipment Gross5,733,318,000USD5,215,090,000USD4,739,089,000USD4,387,348,000USD4,081,691,000USD3,244,477,000USD——
    Accumulated Other Comprehensive Income-901,378,000USD-989,118,000USD-1,402,607,000USD-1,830,970,000USD-445,442,000USD-108,830,000USD-111,965,000USD-79,253,000USD
    Common Stock Shares Outstanding195,214,000shares200,284,000shares204,591,000shares211,210,000shares208,465,000shares204,783,000shares211,840,000shares220,336,000shares
    Non Current Assets Total24,351,039,000USD19,383,854,000USD19,759,920,000USD16,970,858,000USD18,535,196,000USD11,219,128,000USD11,039,926,000USD11,775,466,000USD
    Non Current Liabilities Total17,022,488,000USD12,037,872,000USD13,061,261,000USD13,011,388,000USD15,394,752,999USD11,261,389,000USD6,885,117,999USD7,098,491,999USD
    Non Current Liabilities Other3,639,862,000USD1,993,683,000USD1,884,733,000USD976,583,000USD1,082,723,000USD6,671,798,000USD419,330,000USD—
    Non Currrent Assets Other2,603,974,000USD2,428,765,000USD2,335,698,000USD756,317,000USD726,811,000USD336,332,000USD269,067,000USD270,942,000USD
    Net Working Capital-5,581,466,000USD-6,559,240,000USD-6,032,372,000USD-3,888,197,000USD-2,556,032,000USD-833,224,000USD-1,449,240,000USD—
    Unclassified Non Current Assets-2,603,974,000USD-2,428,765,000USD-3,355,066,000USD-756,317,000USD-726,811,000USD-336,332,000USD-269,067,000USD—
    Unclassified Non Current Liabilities5,839,638,000USD6,232,444,000USD-960,486,000USD——-6,286,291,000USD188,825,999USD7,098,491,999USD
    Unclassified Equity-4,130,778,000USD-3,788,007,000USD-2,405,473,000USD-1,364,089,000USD-1,007,531,000USD-1,434,185,000USD-1,250,315,000USD-711,341,000USD
    Other Liab——7,990,901,000USD7,514,740,000USD8,064,887,000USD7,257,621,000USD2,243,082,000USD—
    Current Deferred Revenue——310,676,000USD—2,856,405,000USD53,149,000USD—1,829,410,000USD
    Net Tangible Assets——-13,483,897,000USD-13,048,182,000USD-14,064,104,000USD-9,611,750,000USD-6,121,426,000USD—
    Unclassified Current Liabilities——-641,344,000USD-789,403,000USD-2,875,548,000USD——-1,529,810,000USD
    Short Term Investments———0USD372,908,000USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-03-31 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USDQ3 20242024-06-30 · USD
    Net Income1,641,332,000USD566,126,000USD-339,704,000USD689,749,000USD717,417,000USD488,600,000USD88,072,000USD487,594,000USD
    Depreciation259,458,000USD260,401,000USD261,012,000USD296,136,000USD-42,183,000USD113,629,000USD-963,000USD280,890,000USD
    Stock Based Compensation-66,054,000USD66,054,000USD25,943,000USD23,184,000USD28,452,000USD70,384,000USD127,431,000USD22,178,000USD
    Other Non Cash Items-1,221,806,000USD187,088,000USD925,633,000USD-81,668,000USD412,910,000USD216,281,000USD610,932,000USD28,873,000USD
    Change To Account Receivables522,077,000USD-830,752,000USD-945,803,000USD-759,565,000USD756,213,000USD-974,256,000USD257,640,000USD-1,336,688,000USD
    Change To Inventory3,399,637,000USD-3,519,839,000USD-319,548,000USD-984,133,000USD1,689,417,000USD-1,655,165,000USD-643,966,000USD-716,610,000USD
    Change In Working Capital481,248,000USD-3,399,200,000USD2,231,087,000USD-801,496,000USD2,208,432,000USD-3,602,599,000USD223,522,000USD1,727,989,000USD
    Total Cash From Operating Activities1,338,639,000USD-2,305,169,000USD3,133,417,000USD109,247,000USD3,351,238,000USD-2,718,782,000USD1,000,379,000USD2,477,592,000USD
    Capital Expenditures-165,618,000USD-119,376,000USD-249,812,000USD-183,216,000USD-129,060,000USD-105,893,000USD-182,324,000USD-117,879,000USD
    Free Cash Flow1,173,021,000USD-2,424,545,000USD2,883,605,000USD-73,969,000USD3,222,178,000USD-2,824,675,000USD818,055,000USD2,359,713,000USD
    Total Cashflows From Investing Activities-4,874,901,000USD-299,315,000USD-321,940,000USD-234,691,000USD-4,077,623,000USD-343,039,000USD-241,885,000USD-143,924,000USD
    Net Borrowings4,111,549,000USD266,212,000USD-582,237,000USD322,404,000USD-332,739,000USD3,788,240,000USD-353,531,000USD—
    Total Cash From Financing Activities3,978,567,000USD43,204,000USD-683,782,000USD215,484,000USD-491,738,000USD3,209,150,000USD-957,260,000USD-1,145,235,000USD
    Dividends Paid-117,456,000USD-126,516,000USD-107,512,000USD-107,493,000USD-111,188,000USD-110,888,000USD-100,945,000USD-102,531,000USD
    Sale Purchase Of Stock0USD7,598,000USD-109,000USD-412,858,000USD-50,000,000USD-385,471,000USD-504,979,000USD-550,010,000USD
    Change In Cash427,569,000USD-2,585,856,000USD2,080,812,000USD96,760,000USD-1,216,408,000USD97,094,000USD-178,516,000USD1,190,359,000USD
    Begin Period Cash Flow1,808,693,000USD4,394,549,000USD2,275,326,000USD2,178,566,000USD3,394,974,000USD3,297,880,000USD3,476,396,000USD2,220,304,000USD
    End Period Cash Flow2,236,262,000USD1,808,693,000USD4,356,138,000USD2,275,326,000USD2,178,566,000USD3,394,974,000USD3,297,880,000USD3,410,663,000USD
    Other Cashflows From Investing Activities10,850,000USD50,457,000USD19,282,000USD-42,460,000USD-3,957,578,000USD-46,117,000USD1,300,974,000USD3,092,000USD
    Other Cashflows From Financing Activities-7,928,000USD-104,090,000USD-553,000USD-6,262,000USD-5,481,000USD-90,839,000USD-4,085,000USD11,636,000USD
    Unclassified Operating Cash Flow244,461,000USD——-16,658,000USD——-48,615,000USD-69,932,000USD
    Unclassified Investing Cash Flow-4,720,133,000USD-230,396,000USD230,530,000USD225,676,000USD4,086,638,000USD152,010,000USD-1,118,650,000USD114,787,000USD
    Investments——-321,940,000USD-234,691,000USD-4,077,623,000USD-343,039,000USD-241,885,000USD-143,924,000USD
    Unclassified Financing Cash Flow———419,693,000USD7,670,000USD——-504,330,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USDFY 20202020-09-30 · USDFY 20192019-09-30 · USDFY 20182018-09-30 · USD
    Net Income1,567,814,000USD1,519,273,000USD1,732,576,000USD1,666,540,000USD1,544,608,000USD-3,399,558,000USD854,135,000USD1,615,892,000USD
    Depreciation1,068,416,000USD448,200,000USD963,904,000USD709,835,000USD514,786,000USD408,013,000USD497,512,000USD510,109,000USD
    Stock Based Compensation147,963,000USD147,998,000USD124,624,000USD93,400,000USD99,594,000USD74,411,000USD58,874,000USD62,316,000USD
    Other Non Cash Items995,639,000USD1,172,850,000USD340,312,000USD176,791,000USD-194,590,000USD4,750,000USD541,586,000USD189,312,000USD
    Change To Account Receivables-1,923,411,000USD-2,784,339,000USD-2,711,786,000USD-1,659,525,000USD-930,078,000USD-1,628,991,000USD-1,241,890,000USD-657,770,000USD
    Change To Inventory-1,269,429,000USD-1,479,599,000USD-2,183,368,000USD-665,370,000USD-1,116,344,000USD-1,621,143,000USD-167,990,000USD-4,923,000USD
    Change In Working Capital35,424,000USD298,688,000USD874,542,000USD-139,662,000USD367,322,000USD6,664,395,000USD363,379,000USD-170,717,000USD
    Total Cash From Operating Activities3,875,120,000USD3,484,685,000USD3,911,334,000USD2,703,088,000USD2,666,586,000USD2,207,040,000USD2,344,023,000USD1,411,388,000USD
    Capital Expenditures-667,981,000USD-487,173,000USD-458,359,000USD-496,318,000USD-438,217,000USD-369,677,000USD-310,222,000USD-336,411,000USD
    Free Cash Flow3,207,139,000USD2,997,512,000USD3,452,975,000USD2,206,770,000USD2,228,369,000USD1,837,363,000USD2,033,801,000USD1,074,977,000USD
    Investments-4,977,293,000USD-618,096,000USD-2,602,465,000USD-368,437,000USD-6,141,577,000USD-379,871,000USD-375,832,000USD—
    Total Cashflows From Investing Activities-4,977,293,000USD-618,096,000USD-2,602,465,000USD-368,437,000USD-6,141,577,000USD-379,871,000USD-375,832,000USD-1,111,114,000USD
    Net Borrowings3,195,668,000USD-385,452,000USD-623,258,000USD-923,103,000USD2,216,552,000USD-32,006,000USD-133,073,000USD—
    Total Cash From Financing Activities2,249,114,000USD-2,330,994,000USD-2,222,278,000USD-1,752,780,000USD1,952,849,000USD-603,617,000USD-1,086,513,000USD-242,873,000USD
    Dividends Paid-437,081,000USD-416,168,000USD-398,752,000USD-391,687,000USD-366,648,000USD-343,578,000USD-338,974,000USD-333,041,000USD
    Sale Purchase Of Stock-435,471,000USD-1,491,367,000USD-1,180,728,000USD-483,704,000USD-82,150,000USD-420,449,000USD-674,031,000USD-639,235,000USD
    Change In Cash1,096,669,000USD544,991,000USD-840,650,000USD523,411,000USD-1,527,618,000USD1,223,552,000USD881,678,000USD57,401,000USD
    Begin Period Cash Flow3,297,880,000USD2,752,889,000USD3,593,539,000USD3,070,128,000USD4,597,746,000USD3,374,194,000USD2,492,516,000USD2,435,115,000USD
    End Period Cash Flow4,394,549,000USD3,297,880,000USD2,752,889,000USD3,593,539,000USD3,070,128,000USD4,597,746,000USD3,374,194,000USD2,492,516,000USD
    Other Cashflows From Investing Activities-17,440,000USD-30,722,000USD-2,144,106,000USD127,881,000USD-5,703,360,000USD-10,194,000USD-1,659,000USD10,596,000USD
    Other Cashflows From Financing Activities-103,135,000USD-75,847,000USD-19,540,000USD-48,198,000USD-13,655,000USD126,061,000USD-16,669,000USD-44,748,000USD
    Unclassified Operating Cash Flow59,864,000USD-102,324,000USD-124,624,000USD196,184,000USD334,866,000USD-1,544,971,000USD28,537,000USD-795,524,000USD
    Unclassified Investing Cash Flow685,421,000USD517,895,000USD2,602,465,000USD368,437,000USD6,141,577,000USD379,871,000USD311,881,000USD-785,299,000USD
    Unclassified Financing Cash Flow29,133,000USD37,840,000USD—93,912,000USD198,750,000USD66,355,000USD76,234,000USD774,151,000USD
    Change To Liabilities——6,103,451,000USD3,320,725,000USD2,049,167,000USD3,300,832,000USD1,561,048,000USD—
    Issuance Of Capital Stock———0USD0USD66,355,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    Days Inventory on Hand

    Period endPeriodValueUnitSource
    2026-06-30quarterly26.6daysDisclosure

    Days Payable Outstanding

    Period endPeriodValueUnitSource
    2026-06-30quarterly59.7daysDisclosure

    Days Sales Outstanding

    Period endPeriodValueUnitSource
    2026-06-30quarterly27.1daysDisclosure

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q3 2026Quarterly · 2026-06-30ProductAnimal Health1,519,782,000USDDisclosure
    Q3 2026Quarterly · 2026-06-30ProductOther Non Strategic Businesses733,548,000USDDisclosure
    Q3 2026Quarterly · 2026-06-30SegmentInternational Healthcare Solutions7,680,456,000USDDisclosure
    Q3 2026Quarterly · 2026-06-30SegmentOther2,213,618,000USDDisclosure
    Q3 2026Quarterly · 2026-06-30SegmentUSHealthcare Solutions74,860,763,000USDDisclosure
    Q2 2026Quarterly · 2026-03-31ProductAnimal Health1,435,789,000USD0001140859-26-000020
    Q2 2026Quarterly · 2026-03-31ProductOther Non Strategic Businesses619,782,000USD0001140859-26-000020
    Q2 2026Quarterly · 2026-03-31SegmentInternational Healthcare Solutions7,565,749,000USD0001140859-26-000020
    Q2 2026Quarterly · 2026-03-31SegmentOther2,025,089,000USD0001140859-26-000020
    Q2 2026Quarterly · 2026-03-31SegmentUSHealthcare Solutions68,765,078,000USD0001140859-26-000020
    Q1 2026Quarterly · 2025-12-31ProductAnimal Health1,471,317,000USD0001140859-26-000006
    Q1 2026Quarterly · 2025-12-31ProductOther Non Strategic Businesses657,630,000USD0001140859-26-000006
    Q1 2026Quarterly · 2025-12-31SegmentInternational Healthcare Solutions7,623,973,000USD0001140859-26-000006
    Q1 2026Quarterly · 2025-12-31SegmentOther2,096,218,000USD0001140859-26-000006
    Q1 2026Quarterly · 2025-12-31SegmentUSHealthcare Solutions76,211,825,000USD0001140859-26-000006
    Q4 2025Quarterly · 2025-09-30SegmentInternational Healthcare Solutions7,944,988,000USDLegacy provider
    Q4 2025Quarterly · 2025-09-30SegmentUSHealthcare Solutions75,788,501,000USDLegacy provider
    FY 2025Yearly · 2025-09-30SegmentInternational Healthcare Solutions30,366,323,000USD0001140859-25-000131
    FY 2025Yearly · 2025-09-30SegmentUSHealthcare Solutions290,982,023,000USD0001140859-25-000131
    Q3 2025Quarterly · 2025-06-30SegmentInternational Healthcare Solutions7,790,438,000USD0001140859-25-000122
    Q3 2025Quarterly · 2025-06-30SegmentUSHealthcare Solutions72,876,563,000USD0001140859-25-000122
    Q2 2025Quarterly · 2025-03-31ProductAnimal Health1,363,032,000USD0001140859-26-000020
    Q2 2025Quarterly · 2025-03-31ProductOther Non Strategic Businesses593,375,000USD0001140859-26-000020
    Q2 2025Quarterly · 2025-03-31SegmentInternational Healthcare Solutions6,696,779,000USD0001140859-26-000020
    Q2 2025Quarterly · 2025-03-31SegmentOther1,937,629,000USD0001140859-26-000020
    Q2 2025Quarterly · 2025-03-31SegmentUSHealthcare Solutions66,819,265,000USD0001140859-26-000020
    Q1 2025Quarterly · 2024-12-31ProductAnimal Health1,379,985,000USD0001140859-26-000006
    Q1 2025Quarterly · 2024-12-31ProductOther Non Strategic Businesses622,470,000USD0001140859-26-000006
    Q1 2025Quarterly · 2024-12-31SegmentInternational Healthcare Solutions6,958,895,000USD0001140859-26-000006
    Q1 2025Quarterly · 2024-12-31SegmentOther1,972,871,000USD0001140859-26-000006
    Q1 2025Quarterly · 2024-12-31SegmentUSHealthcare Solutions72,555,294,000USD0001140859-26-000006
    Q4 2024Quarterly · 2024-09-30SegmentInternational Healthcare Solutions7,382,054,000USDLegacy provider
    Q4 2024Quarterly · 2024-09-30SegmentUSHealthcare Solutions71,671,130,000USDLegacy provider
    FY 2024Yearly · 2024-09-30SegmentInternational Healthcare Solutions28,627,542,000USD0001140859-25-000131
    FY 2024Yearly · 2024-09-30SegmentUSHealthcare Solutions265,339,427,000USD0001140859-25-000131
    FY 2023Yearly · 2023-09-30SegmentInternational Healthcare Solutions27,418,679,000USD0001140859-25-000131
    FY 2023Yearly · 2023-09-30SegmentUSHealthcare Solutions234,759,218,000USD0001140859-25-000131
    FY 2022Yearly · 2022-09-30SegmentInternational Healthcare Solutions26,491,673,000USD0001140859-22-000098
    FY 2022Yearly · 2022-09-30SegmentOther25,707,384,000USD0001140859-22-000098
    FY 2022Yearly · 2022-09-30SegmentUSHealthcare Solutions186,387,949,000USD0001140859-22-000098
    FY 2021Yearly · 2021-09-30SegmentInternational Healthcare Solutions11,529,629,000USD0001140859-23-000197
    FY 2021Yearly · 2021-09-30SegmentUSHealthcare Solutions202,461,545,000USD0001140859-23-000197
    FY 2020Yearly · 2020-09-30SegmentAll Other Segments — Global Commercialization Services3,308,640,000USD0001140859-20-000050
    FY 2020Yearly · 2020-09-30SegmentAll Other Segments — MWIAnimal Health4,216,462,000USD0001140859-20-000050
    FY 2020Yearly · 2020-09-30SegmentPharmaceutical Distribution182,467,189,000USD0001140859-20-000050
    FY 2019Yearly · 2019-09-30SegmentAll Other Segments — Global Commercialization Services2,893,109,000USD0001140859-20-000050
    FY 2019Yearly · 2019-09-30SegmentAll Other Segments — MWIAnimal Health3,975,232,000USD0001140859-20-000050
    FY 2019Yearly · 2019-09-30SegmentPharmaceutical Distribution172,813,537,000USD0001140859-20-000050
    Q2 2019Quarterly · 2019-03-31ProductInterconnection Revenue18,416,000USD0001558370-19-003347
    Q2 2019Quarterly · 2019-03-31ProductOffice Light Industrial And Other Revenue2,626,000USD0001558370-19-003347
    Q2 2019Quarterly · 2019-03-31ProductRental Power And Related Revenue117,853,000USD0001558370-19-003347
    Q4 2018Quarterly · 2018-09-30ProductInterconnection Revenue17,701,000USD0001558370-18-007910
    Q4 2018Quarterly · 2018-09-30ProductPower Revenue0USD0001558370-18-007910
    Q4 2018Quarterly · 2018-09-30ProductRental Power And Related Revenue118,590,000USD0001558370-18-007910
    Q4 2018Quarterly · 2018-09-30ProductTenant Reimbursement And Other Revenue2,889,000USD0001558370-18-007910
    FY 2018Yearly · 2018-09-30SegmentAll Other Segments — Global Commercialization Services2,542,971,000USD0001140859-20-000050
    FY 2018Yearly · 2018-09-30SegmentAll Other Segments — MWIAnimal Health3,789,759,000USD0001140859-20-000050
    FY 2018Yearly · 2018-09-30SegmentPharmaceutical Distribution161,699,343,000USD0001140859-20-000050
    Q2 2018Quarterly · 2018-03-31ProductInterconnection Revenue16,560,000USD0001558370-19-003347
    Q2 2018Quarterly · 2018-03-31ProductOffice Light Industrial And Other Revenue3,051,000USD0001558370-19-003347
    Q2 2018Quarterly · 2018-03-31ProductRental Power And Related Revenue110,008,000USD0001558370-19-003347
    FY 2017Yearly · 2017-12-31ProductInterconnection Revenue62,293,000USD0001558370-19-000493
    FY 2017Yearly · 2017-12-31ProductPower Revenue0USD0001558370-19-000493
    FY 2017Yearly · 2017-12-31ProductRental Power And Related Revenue407,680,000USD0001558370-19-000493
    FY 2017Yearly · 2017-12-31ProductTenant Reimbursement And Other Revenue11,848,000USD0001558370-19-000493
    FY 2016Yearly · 2016-12-31ProductInterconnection Revenue53,077,000USD0001558370-19-000493
    FY 2016Yearly · 2016-12-31ProductPower Revenue0USD0001558370-19-000493
    FY 2016Yearly · 2016-12-31ProductRental Power And Related Revenue338,687,000USD0001558370-19-000493
    FY 2016Yearly · 2016-12-31ProductTenant Reimbursement And Other Revenue8,588,000USD0001558370-19-000493

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.